Medpace
MEDP
416 hedge funds and large institutions have $4.68B invested in Medpace in 2023 Q1 according to their latest regulatory filings, with 49 funds opening new positions, 171 increasing their positions, 144 reducing their positions, and 48 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 171 | Existing positions reduced: 144
2.88% more ownership
Funds ownership: 78.19% → 81.08% (+2.9%)
2% more first-time investments, than exits
New positions opened: 49 | Existing positions closed: 48
1% less funds holding
Funds holding: 422 → 416 (-6)
7% less capital invested
Capital invested by funds: $5.04B → $4.68B (-$357M)
38% less funds holding in top 10
Funds holding in top 10: 8 → 5 (-3)
50% less call options, than puts
Call options by funds: $3.72M | Put options by funds: $7.41M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$73.2M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$45.7M |
| 3 |
UBS AM
Chicago,
Illinois
|
+$39.9M |
| 4 |
Goldman Sachs
New York
|
+$33.6M |
| 5 |
Renaissance Technologies
New York
|
+$19.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
-$62.9M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$42.9M |
| 3 |
Man Group
London,
United Kingdom
|
-$27.7M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$23.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$10.4M |
MEDP Hedge Fund Activity: Q1 2023 in Review
416 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q1 2023, worth a combined $4.68B — down 7.1% from $5.04B a quarter earlier.
Buyers outnumbered sellers: 49 funds opened new MEDP positions and 48 closed out — a net gain of 1 holder — while 171 added to existing stakes and 144 trimmed.
The largest buyer was Envestnet Asset Management, adding an estimated $73.2M. The largest seller was Thrivent Financial for Lutherans, cutting an estimated $62.9M.
- 416 institutional investors held Medpace (MEDP) as of Q1 2023, down from 422 in Q4 2022.
- Funds reported $4.68B of Medpace stock for Q1 2023, down 7.1% quarter-over-quarter.
- 49 funds opened new Medpace positions in Q1 2023 and 48 closed out, a net change of +1 holder.
- The largest Medpace buyer in Q1 2023 was Envestnet Asset Management, an estimated $73.2M added.
- The largest Medpace seller in Q1 2023 was Thrivent Financial for Lutherans, an estimated $62.9M sold.
Based on aggregated 13F filings for Q1 2023.